Cutaneous adverse drug reactions: Enhanced imputation score by skin testing;Réactions cutanées médicamenteuses: La réalisation de tests cutanés augmente le score d'irnputabilité

Annales de Dermatologie et de Venereologie

Volumn 128, Issue 4, 2001, Pages 507-511

  Choquet Kastylevsky, G ^a,c   Vial, T ^a   Santolaria, N ^a   Nageotte, A ^b   Faure, M ^c   Claudy, A ^c   Descotes, J ^a  

^a Centre de Pharmacovigilance   (France)

^b Hospital Pharmacy   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ALGIPAN; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ARTOTEC; BENZYL BENZOATE; BEZAFIBRATE; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; CEFTRIAXONE; CIPROFLOXACIN; CODEINE CAMSILATE; COTRIMOXAZOLE; DIFFERINE; DYDROGESTERONE; HEXAPNEUMINE; HOMEOPLASMINE; HYDROXYZINE; LINCOCINE; LINCOMYCIN; LOBAMINE CYSTEINE; METHIONINE; MINOCYCLINE; NADROPARIN; NAPROXEN; ORALFENE; OROPIVALONE; OXOMEMAZINE; PARACETAMOL; PINAVERIUM BROMIDE; PIROXICAM; POVIDONE IODINE; PREDNISOLONE 3 SULFOBENZOATE; PRISTINAMYCIN; ROXITHROMYCIN; TETRAZEPAM; TIXOCORTOL PIVALATE; VAGOSTABYL;

ARTICLE; CLINICAL ARTICLE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; ECZEMA; HUMAN; HYPERSENSITIVITY REACTION; RELAPSE; SCORING SYSTEM; SKIN MANIFESTATION; SKIN TEST; URTICARIA;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; DRUG ERUPTIONS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; PROSPECTIVE STUDIES; RECURRENCE; SEVERITY OF ILLNESS INDEX; SKIN TESTS; TIME FACTORS;

EID: 0035011781     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Breathnach SM. Mechanisms of drug eruptions : part 1. Austral J Dermatol 1995;36:121-7.
2. Breathnach SM, Hintner H. Réactions cutanées médicamenteuses. Arnette, Paris, 1993.
3. Roujeau JC, Kelly J, Naldi L, Rzany B, Stern RS, Arderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
4. Roujeau JC, Stern RS Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;333:1272-85.
5. Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Thérapie 1985;40:111-8.
6. Barbaud A, Reichert-Penetrat S, Trechot P. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139:49-58.
7. DeLeo V. Skin testing in systemic cutaneous drug reactions. Lancet 1998;352:1488-90.
8. Barbaud A, Trechot P, Bene MC, Reichert S, Granel F, Faure G, et al. Relevance of drug skin tests in investigating cutaneous adverse drug reactions (CADR) [Abstract]. Contact Dermatitis 2000;42(S2):12-3.
9. Lee AY. Topical provocation in 31 cases of fixed drug eruption : change of causative drugs in 10 years. Contact Dermatitis 1998;38:258-60.
10. Calkin JM, Maibach HI. Delayed hypersensitivity drug reactions diagnosed by patch testing. Contact Dermatitis 1993;29:223-33.
11. Wolkenstein P, Chosidow O, Flechet ML, Robbiola O, Paul M, Dume L, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996;35:234-6.
12. Alanko C. Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis 1993;29:254-7.
13. Camarasa JG, Serra-Baldrich E. Tetrazepam allergy detected by patch test. Contact Dermatitis 1990;22:246.
14. Collet E, Dalac S, Morvan C, Sgro C, Lambert D. Tetrazepam allergy once more detected by patch test. Contact Dermatitis 1992;26:281.
15. Vaillant L, Camenen I, Lorette G. Patch-testing with carbamazepine : reintroduction of an exfoliative dermatitis. Arch Dermatol 1989;125:299.
16. Vaillant L, Machet L, Lorette G. Commentaires : Les tests épicutanés ont-ils valeurs d'un test de réintroduction en dermatologie ? Thérapie 1993;48:157-61.